Changes (2909)
Every movement the pipeline observed across all networks — payouts, statuses, geos, caps, metrics — as it happened. Subscribe: Atom feed
| When | Network | Offer | Change |
|---|---|---|---|
| 9h ago | AdCombo | Diobene low - GT | Approval rate 61.23% → 61.33% (+0.2%) |
| 9h ago | AdCombo | Diobene 649 - MX | Approval rate 60.92% → 56.9% (-6.6%) |
| 9h ago | AdCombo | Upvision - RO | Approval rate 42.44% → 41.42% (-2.4%) |
| 9h ago | AdCombo | Sustarox - PY | Approval rate 56.49% → 62.46% (+10.6%) |
| 9h ago | AdCombo | Fungokiller - GR | Approval rate 16% → 36.33% (+127.1%) |
| 9h ago | AdCombo | Flexacil Ultra (caps) - CO | Approval rate 31.57% → 36.33% (+15.1%) |
| 9h ago | AdCombo | GlucoFortex - MX | Approval rate 53% → 78% (+47.2%) |
| 9h ago | AdCombo | Cardionix - MX | Approval rate 29.83% → 29.33% (-1.7%) |
| 9h ago | AdCombo | Proctowell - HU | Approval rate 60.14% → 78% (+29.7%) |
| 9h ago | AdCombo | Detoxil Water Parasites - DE, AT | Approval rate 19.67% → 13% (-33.9%) |
| 9h ago | AdCombo | Audix - PE | Approval rate 43.18% → 41.79% (-3.2%) |
| 9h ago | AdCombo | Hondro Sol - ES | Approval rate 90% → 69.67% (-22.6%) |
| 9h ago | AdCombo | LutexID - AR | Approval rate 36.33% → 43% (+18.4%) |
| 9h ago | AdCombo | Venisal - RS | Approval rate 70.31% → 68% (-3.3%) |
| 9h ago | AdCombo | Herbolo - BA | Approval rate 78% → 69.67% (-10.7%) |
| 9h ago | AdCombo | Proctowell - RO | Approval rate 42.44% → 36.1% (-14.9%) |
| 9h ago | AdCombo | Yenki Derm - DE, AT | Approval rate 24.09% → 22.53% (-6.5%) |
| 9h ago | AdCombo | Yenki Derm - MX | Approval rate 21.83% → 21.77% (-0.3%) |
| 9h ago | AdCombo | U Caps - BG | Approval rate 49.8% → 50.48% (+1.4%) |
| 9h ago | AdCombo | U Caps - XK | Approval rate 53% → 28% (-47.2%) |
| 9h ago | AdCombo | U Caps - AL | Approval rate 84.82% → 78% (-8.0%) |
| 9h ago | AdCombo | Fungokiller - DE, AT | Approval rate 14.11% → 15.5% (+9.9%) |
| 9h ago | AdCombo | Fungokiller - IT | Approval rate 26.33% → 20.24% (-23.1%) |
| 9h ago | AdCombo | Oxys - UY | Approval rate 49.04% → 49.67% (+1.3%) |
| 9h ago | AdCombo | Toxic OFF - MX | Approval rate 29.32% → 28.46% (-2.9%) |
| 9h ago | AdCombo | Joinflex - CO | Approval rate 64.54% → 61.33% (-5.0%) |
| 9h ago | AdCombo | Cardiotensive - ES | Approval rate 55.04% → 59.89% (+8.8%) |
| 9h ago | AdCombo | Flemona - MX | Approval rate 29.3% → 28.36% (-3.2%) |
| 9h ago | AdCombo | Glow Drink - CO | Approval rate 32.07% → 32.27% (+0.6%) |
| 9h ago | AdCombo | TurboSlim - PE | Approval rate 37.59% → 37.1% (-1.3%) |
| 9h ago | AdCombo | Glyconorm - PE | Approval rate 55.94% → 61.82% (+10.5%) |
| 9h ago | AdCombo | Papaya cleanse - PE | Approval rate 43.51% → 43.43% (-0.2%) |
| 9h ago | AdCombo | TurboSlim - CL | Approval rate 35.2% → 34.62% (-1.6%) |
| 9h ago | AdCombo | Cardiox - CL | Approval rate 48.45% → 53% (+9.4%) |
| 9h ago | AdCombo | UpVision - MX | Approval rate 23% → 22.05% (-4.1%) |
| 9h ago | AdCombo | Elesse Cream - ES | Approval rate 56.38% → 55.04% (-2.4%) |
| 9h ago | AdCombo | Rico Boost - MX | Approval rate 27.45% → 27.52% (+0.3%) |
| 9h ago | AdCombo | Magicoa - EC | Approval rate 43% → 36.33% (-15.5%) |
| 9h ago | AdCombo | Fortuflex - IT | Approval rate 56.68% → 55.94% (-1.3%) |
| 9h ago | AdCombo | Simpla 360 - EC | Approval rate 21.67% → 19.67% (-9.2%) |
| 9h ago | AdCombo | Motion Energy - EC | Approval rate 27.05% → 25.63% (-5.2%) |
| 9h ago | AdCombo | Vizonic - IT | Approval rate 56.68% → 55.94% (-1.3%) |
| 9h ago | AdCombo | Mikoherb - HR | Approval rate 53% → 90% (+69.8%) |
| 9h ago | AdCombo | Simpla 360 - CO | Approval rate 32.03% → 32.27% (+0.7%) |
| 9h ago | AdCombo | Hondro Sol - FR | Approval rate 22.96% → 23.08% (+0.5%) |
| 9h ago | AdCombo | Magicoa - PE | Approval rate 37.59% → 37.06% (-1.4%) |
| 9h ago | AdCombo | Magicoa - MX | Approval rate 24.74% → 25.1% (+1.5%) |
| 9h ago | AdCombo | Duston Gel - UY | Approval rate 68.32% → 69.05% (+1.1%) |
| 9h ago | AdCombo | Simpla 360 - MX | Approval rate 27.53% → 26.53% (-3.6%) |
| 9h ago | AdCombo | Matcha Suri - SV | Approval rate 22.64% → 23.37% (+3.2%) |